Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The use of population-based serum drug concentration cutoff values for several commonly monitored drugs as tests to distinguish toxicity from nontoxicity was studied. Serum drug concentration and response data published in studies of theophylline, digoxin, aminoglycosides, vancomycin, and procainami...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/2242660
データ提供:米国国立医学図書館(NLM)
Predicting Toxicity: Navigating the Desert of Drug Concentrations
In the vast desert of drug concentrations, finding the perfect balance between efficacy and safety is a constant challenge. This study explores the use of population-based serum drug concentration cutoff values as a tool to predict toxicity. The researchers analyzed data from several commonly monitored drugs, aiming to improve therapeutic drug monitoring and enhance patient safety.The Shifting Sands of Sensitivity and Specificity
The study found that using fixed cutoff values for drug concentrations has limitations. As the cutoff value increases, specificity improves, but sensitivity decreases, creating a delicate balance. This highlights the need for a more nuanced approach, taking into account individual patient factors and a Bayesian interpretation of the data.The Importance of Personalized Care in a World of Drugs
The study emphasizes the need for personalized approaches to drug therapy. By combining a Bayesian interpretation with a more patient-specific approach, healthcare providers can tailor treatment to individual needs, optimizing therapeutic outcomes while minimizing the risk of toxicity. This underscores the importance of collaboration between healthcare professionals and laboratory personnel in navigating the complexities of drug therapy.Dr.Camel's Conclusion
This research sheds light on the need for personalized and collaborative approaches to therapeutic drug monitoring. By incorporating a Bayesian perspective, healthcare providers can navigate the desert of drug concentrations, optimizing patient care and ensuring a safe and effective therapeutic journey.Date :
- Date Completed 1991-01-03
- Date Revised 2013-11-21
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.